California Public Employees Retirement System’s Aegerion Pharmaceuticals AEGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-64,100
Closed -$190K 3500
2016
Q3
$190K Sell
64,100
-4,500
-7% -$7.8K ﹤0.01% 3118
2016
Q2
$102K Sell
68,600
-2,200
-3% -$5.03K ﹤0.01% 3322
2016
Q1
$262K Sell
70,800
-4,300
-6% -$26.6K ﹤0.01% 3026
2015
Q4
$759K Hold
75,100
﹤0.01% 2564
2015
Q3
$1.02M Sell
75,100
-41,000
-35% -$730K ﹤0.01% 2350
2015
Q2
$2.2M Buy
116,100
+41,000
+55% +$887K ﹤0.01% 1983
2015
Q1
$1.85M Hold
75,100
﹤0.01% 2188
2014
Q4
$1.85M Buy
75,100
+51,600
+220% +$1.3M ﹤0.01% 2188
2014
Q3
$784K Hold
23,500
﹤0.01% 2667
2014
Q2
$754K Sell
23,500
-6,658
-22% -$248K ﹤0.01% 2741
2014
Q1
$1.26M Sell
30,158
-34,355
-53% -$2.01M ﹤0.01% 2382
2013
Q4
$4.52M Buy
64,513
+39,713
+160% +$3.04M 0.01% 1487
2013
Q3
$2.13M Buy
24,800
+7,700
+45% +$653K ﹤0.01% 1890
2013
Q2
$1.08M Buy
+17,100
New +$908K ﹤0.01% 2209

California Public Employees Retirement System's AEGR Position: Q4 2016 in Review

California Public Employees Retirement System sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2016, closing a stake of 64,100 shares — an estimated $190K sold.

California Public Employees Retirement System first reported a position in AEGR in Q2 2013 and held it in 14 quarters. The position peaked at $4.52M in Q4 2013. 0 funds tracked by Wall St. Rank hold AEGR as of Q4 2016.

  • California Public Employees Retirement System reported no remaining Aegerion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • California Public Employees Retirement System sold 64,100 Aegerion Pharmaceuticals shares in Q4 2016, an estimated $190K.
  • California Public Employees Retirement System first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 14 quarters.
  • California Public Employees Retirement System's Aegerion Pharmaceuticals position peaked at $4.52M in Q4 2013.
  • 0 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2016.

Based on California Public Employees Retirement System's 13F filing for Q4 2016, filed 10 Feb 2017.